Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Dumitru Moldovan"'
Autor:
Vesna Grivcheva-Panovska, Markus Magerl, Henriette Farkas, Avner Reshef, Stephen Fritz, Dumitru Moldovan, Bruno Giannetti, Aharon Kessel, Vaclava Gutova, Anurag Relan, Shmuel Kivity, Maria Klimaszewska-Rembiasz
Publikováno v:
Pediatric Allergy and Immunology
Background Attacks of hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency (C1‐INH‐HAE) usually begin during childhood or adolescence. However, limited data are available regarding indications and modalities of treatment of childre
Autor:
Jennifer Schranz, Jim Christensen, Kraig W. Jacobson, Emel Aygören-Pürsün, Inmaculada Martinez-Saguer, Yongqiang Tang, D. Soteres, Arthur Van Leerberghe, Moshe Y. Vardi, Peng Lu, Dumitru Moldovan, Sandra A. Nieto-Martinez
Publikováno v:
Pediatric Allergy and Immunology
Background Patients with hereditary angioedema with C1 inhibitor deficiency or dysfunction have burdensome recurrent angioedema attacks. The safety, efficacy, and health-related quality of life (HRQoL) outcomes of C1 inhibitor (C1-INH) prophylaxis (i
Autor:
Inmaculada Martinez-Saguer, James Hao, Jim Christensen, D. Soteres, Dumitru Moldovan, Arthur Van Leerberghe, Jennifer Schranz, Emel Aygören-Pürsün, Kraig W Jacobson
Publikováno v:
International Archives of Allergy and Immunology. 173:114-119
Background: Hereditary angioedema (HAE) is a rare genetic disease causing unpredictable and potentially life-threatening subcutaneous and submucosal edematous attacks. Cinryze® (Shire ViroPharma Inc., Lexington, MA, USA), a nanofiltered C1 inhibitor
Autor:
Mikhail Rojavin, Dumitru Moldovan, Debora Williams-Herman, Krystyna Obtułowicz, Henrike Feuersenger, Jonathan M. Edelman, Todor Shirov, Thomas Machnig, Henriette Farkas, Lilian Varga
Publikováno v:
Annals of Allergy, Asthma & Immunology. 117:508-513
Background Limited data are available regarding C1 inhibitor (C1-INH) administration and anti–C1-INH antibodies. Objective To assess the incidence of antibody formation during treatment with pasteurized, nanofiltered plasma-derived C1-INH (pnfC1-IN
Autor:
Werner Aberer, David Hagin, Emel Aygören-Pürsün, Vesna Grivcheva-Panovska, Melanie Cornpropst, Dumitru Moldovan, Avner Reshef, Claire Bethune, Sylvia Dobo, Marcus Maurer, Aarnoud Huissoon, Sharon VanDyke, William Rae, David Launay, Phillip J. Collis, S. Murray, Anette Bygum, Henriette Farkas, Sorena Kiani, Saul N. Faust, Marco Cicardi, Marcin Stobiecki, William P. Sheridan, Hilary Longhurst, Urs C. Steiner
Publikováno v:
Longhurst, H, Moldovan, D, Bygum, A, Cicardi, M, Huissoon, A, Aygoren-Pursun, E, Grivcheva-Panovska, V, Hagin, D, Steiner, U, Stobiecki, M, Aberer, W, Bethune, C, Faust, S N, Kiani, S, Launay, D, Maurer, M, Rae, W, Reshef, A, Cornpropst, M T, Dobo, S M, VanDyke, S, Murray, S, Collis, P J, Sheridan, W P & Farkas, H 2019, ' Oral Plasma Kallikrein Inhibitor BCX7353 is Safe and Effective as an On-Demand Treatment of Angioedema Attacks in Hereditary Angioedema (HAE) Patients: Results of the ZENITH-1 Trial ', Journal of Allergy and Clinical Immunology, vol. 143, no. Suppl. 2, pp. AB37 . https://doi.org/10.1016/j.jaci.2018.12.112
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::211e7b789174de854b5d955e578c58c3
https://portal.findresearcher.sdu.dk/da/publications/20b337db-1cb2-4079-ac7a-6ac16636a51c
https://portal.findresearcher.sdu.dk/da/publications/20b337db-1cb2-4079-ac7a-6ac16636a51c
Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy
Autor:
Dumitru Moldovan, Roman Hakl, Anurag Relan, William R. Lumry, Kimberly Poarch, Jonathan A. Bernstein, Grzegorz Porebski
Hereditary angioedema (HAE) is a rare (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea878cf3b651375691ae3362483d42fe
https://ruj.uj.edu.pl/xmlui/handle/item/255949
https://ruj.uj.edu.pl/xmlui/handle/item/255949
Autor:
William R. Lumry, Inmaculada Martinez-Saguer, William H. Yang, Jonathan A. Bernstein, Joshua Jacobs, Dumitru Moldovan, Marc A. Riedl, Douglas T. Johnston, H. Henry Li, Yongqiang Tang, Jennifer Schranz, Peng Lu, Moshe Vardi, Henriette Farkas, P. Keith, W. Yang, M. Maurer, I. Martinez-Saguer, H. Farkas, A. Reshef, S. Kivity, D. Moldovan, T. Caballero, M. Guilarte, M.D. Hernandez, M.T. González-Quevedo, A. Banerji, J. Bernstein, A. Bewtra, T. Craig, S. Fineman, R. Gower, J. Jacobs, D. Johnston, J. Kashkin, H.H. Li, W.R. Lumry, M. Manning, D. McNeil, I. Melamed, N. Mumneh, T. Nickel, J. Panuto, D. Soteres, R. Tachdjian, J. Offenberger, J. Wedner
Publikováno v:
The journal of allergy and clinical immunology. In practice. 7(5)
Hereditary angioedema (HAE) with C1 inhibitor deficiency (C1-INH) is characterized by swelling of subcutaneous and/or submucosal tissues.To evaluate efficacy/safety of fixed-dose subcutaneous plasma-derived C1-INH (pdC1-INH) liquid for HAE attack pre
Autor:
I. J. Ansotegui, Bruce L. Zuraw, Stephen Betschel, Marcus Maurer, Alexander Nast, Paul Potter, Marc A. Riedl, Inmaculada Martinez-Saguer, Mario Sánchez-Borges, Henriette Farkas, Ruby Pawankar, Emel Aygören-Pürsün, Bruce Ritchie, Constance H. Katelaris, Hilary Longhurst, Lanny J. Rosenwasser, W. R. Lumry, Timothy J. Craig, R. Lockey, Markus Magerl, Yuxiang Zhi, Michihiro Hide, Dumitru Moldovan, Tom Bowen, Konrad Bork, H. Balle Boysen, Anete Sevciovic Grumach
Publikováno v:
World Allergy Organization Journal
Hereditary Angioedema (HAE) is a rare and disabling disease. Early diagnosis and appropriate therapy are essential. This update and revision of the global guideline for HAE provides up-to-date consensus recommendations for the management of HAE. In t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57386d1ba42ac4a5f55b4701075ace83
Autor:
Matthaios Speletas, Nick Koutsostathis, Henriette Farkas, Dumitru Moldovan, Dorottya Csuka, Markus Magerl, Marcus Maurer, Ágnes Szilágyi, Anastasios E. Germenis, Maria Kompoti, Fotis Psarros, Lilian Varga
Publikováno v:
Allergy. 70:1661-1664
The factors influencing the heterogeneous clinical manifestation of hereditary angioedema due to C1-INH deficiency (C1-INH-HAE) represent one of the oldest unsolved problems of the disease. Considering that factor XII (FXII) levels may affect bradyki
Autor:
S. Nieto-Martinez, Dumitru Moldovan, D. Soteres, J. Baptista, Kraig W. Jacobson, M. Vardi, Inmaculada Martinez-Saguer, Emel Aygören-Pürsün
Publikováno v:
Annals of Allergy, Asthma & Immunology. 121:S36
Introduction Adherence in a pediatric population can be a barrier to therapy. Here we report compliance, safety, efficacy and QoL outcomes in patients aged 6-11years who received intravenous (IV) C1-INH for routine prevention of angioedema attacks. M